Effect of VEGF antisense oligonucleotides combined with low molecular weight heparin on the growth and metastasis of mice Lewis lung cancer

Y. Zhang, C. Wang, B. Pang (Beijing, China)

Source: Annual Congress 2007 - Biology in thoracic oncology
Session: Biology in thoracic oncology
Session type: Oral Presentation
Number: 4240
Disease area: Thoracic oncology

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Y. Zhang, C. Wang, B. Pang (Beijing, China). Effect of VEGF antisense oligonucleotides combined with low molecular weight heparin on the growth and metastasis of mice Lewis lung cancer. Eur Respir J 2007; 30: Suppl. 51, 4240

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Effect of vascular endothelial growth factor antisense oligonucleotides and low molecular weight heparin on pulmonary thromboembolism in mice with Lewis lung cancer
Source: Annual Congress 2006 - Lung cancer staging and miscellaneous
Year: 2006


The effects of dalteparin, a kind of low molecular weight heparin, on lung adenocarcinoma A549 cell line in vitro
Source: Annual Congress 2008 - Biology and diagnosis of thoracic tumours
Year: 2008

Benzamidine-type urokinase inhibitors reduce primary tumor growth in a Lewis lung carcinoma model
Source: Eur Respir J 2005; 26: Suppl. 49, 92s
Year: 2005

Inhibition of tumor growth and metastatic lung tumors in mice by adenovirus-mediated interferon-β gene therapy
Source: Eur Respir J 2003; 22: Suppl. 45, 199s
Year: 2003

Adenovirus-mediated interferon-beta gene therapy inhibits tumor growth and inhibits metastatic lung tumors in mice
Source: Eur Respir J 2002; 20: Suppl. 38, 186s
Year: 2002

Tissue inhibitor of metalloproteinase 3 inhibits growth of lung cancer tumours in nude mice
Source: Eur Respir J 2004; 24: Suppl. 48, 704s
Year: 2004

Adenovirus-mediated interferon-β gene therapy combined with radiotherapy synergistically inhibits lung tumor growth in mice
Source: Eur Respir J 2004; 24: Suppl. 48, 79s
Year: 2004

Interleukin-17 enhances the net angiogenic potential and in vivo growth of human non-small cell lung cancer in SCID mice through promoting CXCR-2-dependent angiogenesis
Source: Eur Respir J 2004; 24: Suppl. 48, 79s
Year: 2004

Inhibition of the effect of epidermal growth factor (EGF) on lung cancer cells. The use of plasmids encoding specific siRNA molecules
Source: International Congress 2015 – Biomarkers, immunology and molecular pathology of lung cancer
Year: 2015

Intratracheal administration of dry powdered low-molecular-weight chitosan/siRNA complexes suppressed gene expression in the airway and metastatic tumors in murine lung
Source: Annual Congress 2012 - New drug targets and pre-clinical models for respiratory diseases
Year: 2012


Inhibitory effects of shRNA targeting layilin on adhesion and invasion behavior of human lung carcinoma cell A549 induced by hyaluronan in vitro
Source: Eur Respir J 2006; 28: Suppl. 50, 855s
Year: 2006

Targeting gene of insulin-like growth factor type I (IGF-I) on in vitro model of A549 cell line with triple-helix approach. Perspectives of gene therapy in non-small cell lung (NSCLC) cancer
Source: Eur Respir J 2006; 28: Suppl. 50, 387s
Year: 2006

The effect of siRNA on invasion capability of small cell lung cancer
Source: Annual Congress 2012 - New aspects of lung cancer biology
Year: 2012

Specific plasmids encoding shRNA molecules directed against growth factor receptors in cell proliferation inhibition and induction phenotype changes relevant to enhancement of anti-tumor immunity. Model of human non-small (NSCLC) and small (SCLC) cell lung cancer lines
Source: Annual Congress 2010 - Pathology of lung cancer
Year: 2010

Expression of vascular endothelial growth factor (VEGF) and its receptors (VEFG-R1-Flt1, VEGF-R2-Flk1) in non small cell lung carcinomas (NSCLC): correlation with lymphangiogenesis and clinical outcome
Source: Annual Congress 2007 - Diagnosis and prognosis in thoracic oncology
Year: 2007


Expression of vascular endothelial growth factor (VEGF) and association with lymphangiogenesis in non small cell (NSCLC) and small cell lung carcinomas (SCLC)
Source: Eur Respir J 2006; 28: Suppl. 50, 386s
Year: 2006

The human endogenous antibiotic LL-37 promotes growth of lung cancer cells
Source: Eur Respir J 2006; 28: Suppl. 50, 153s
Year: 2006

The neoadjuvant therapy of NSCLC down-regulates serum levels of growth factors (VEGF, bFGF, TGF-beta) with no effect on apoptosis (CD95L) and local tumour invasiveness markers (TIMP-1)
Source: Eur Respir J 2006; 28: Suppl. 50, 386s
Year: 2006

Intratumoral injection of plasmid-encoded flagellin inhibits growth of NSCLC-cells in murine lung cancer model
Source: Annual Congress 2012 - Treatment of lung cancer
Year: 2012

Downregulation of expression growth factor receptor induced by vector-based siRNA and its effect on radiosensitivity of pulmonary adenocarcinoma cell line
Source: Eur Respir J 2006; 28: Suppl. 50, 810s
Year: 2006